Cannabidiol (CBD) is one of many cannabinoids present in hemp and marijuana, two different kinds of cannabis plants. CBD may assist patients with cancer to manage a few of the disease’s symptoms, as well as treatment adverse effects. Scientists are also investigating how CBD might help with cancer treatment, but more study is needed before any conclusions can be drawn.
Cannabis, sometimes known as marijuana, contains enough tetrahydrocannabinol (THC) to make you high, but hemp does not. CBD is psychotropic, but unlike THC, it is not intoxicating or euphoric. Some CBD products, however, may contain trace levels of THC. Let’s take a deeper look at how CBD Edibles may benefit cancer patients.
CBD as a cancer therapy
In animal models of cancer, there is strong evidence that cannabis can decrease tumor development. CBD may potentially improve the absorption or efficacy of certain cancer-treatment medicines.
Here is a little research that looks promising:
A look ahead to 2019. Cannabinoids have been reported to aid decrease tumor development, inhibit tumor invasion, and cause tumor cell death in vitro and in vivo studies concentrating on pancreatic cancer. According to the study’s authors, research on the efficacy of various formulations, dosage, and exact mode of action is inadequate and urgently needed.
According to 2019 research, CBD can cause cell death and make nuroblastoma cells more susceptible to radiation, but has no effect on healthy cells.
Comprehensive, long-term research of males in the California Men’s Health Study cohort discovered that cannabis use may be inversely related to bladder cancer risk. A cause and effect link, however, has not been demonstrated.
According to a 2014 research in vivo experimental models of colon cancer, CBD may prevent the spread of colorectal cancer cells.
Cannabinoids are promising chemicals in the treatment of gliomas, according to a 2014 assessment of 35 in vitro and in vivo trials.
CBD was found to be effective in preclinical models of metastatic breast cancer in a study published in 2010. CBD was shown to dramatically inhibit breast cancer cell growth and invasion in the research.
These are just a handful of the studies that have looked at the potential of cannabis to help treat cancer. Still, it is still too early to declare CBD to be a safe and effective cancer therapy in humans. CBD should not be used in place of conventional cancer therapies.
CBD as a cancer therapy supplement
Cancer therapies, such as chemotherapy and radiation, can cause a variety of adverse effects, including nausea and loss of appetite, which can result in weight loss. Cannabinoids may help with neuropathic pain and nausea, according to research. THC has been proven to enhance low appetite caused by cancer and cancer therapy, but CBD has been shown to decrease it. CBD may have anti-inflammatory and anti-anxiety effects. So yet, only one CBD product has been approved by the Food and Drug Administration (FDA).
Epidiolex is that product, and it is exclusively used to treat two uncommon types of epilepsy. No CBD products have been authorized by the FDA to treat cancer or its symptoms or to alleviate the adverse effects of cancer therapy. Two synthetic THC medicines, on the other hand, have been authorized to treat chemotherapy-induced nausea and vomiting. THC is present in dronabinol capsules (Marinol) and tinctures (Syndrome). Nabilone (Cesamet) is a synthetic cannabinoid that is taken orally and works similarly to THC.
Nabiximols, another cannabis medication, is accessible in Canada and portions of Europe. It is a THC and CBD mouth spray that has shown potential in relieving cancer pain. It is not yet approved in the United States, although it is being studied. If you’re thinking about taking medicinal marijuana, consult with your doctor about the best way to do it. For patients with certain forms of cancer, smoking may not be a smart option. CBD and other cannabis products are available in a variety of formats, including vape, tincture, sprays, and oils. They are also present in chocolates, coffee, and other foods.
CBD as a cancer-prevention agent
Studies on the function of cannabis in cancer development have shown conflicting results. A mouse model was utilized in a 2010 research to investigate the effects of cannabinoids, especially THC, on immune system suppression. The study discovered evidence that THC can inhibit the immune system, however, whether this raises the risk of cancer is unknown.
CBD research has a long way to go in terms of cancer prevention. Long-term studies of persons who use specific CBD products will be required, with the frequency of usage, dosage, and other factors controlled for.
CBD should not be used in place of conventional cancer therapies. More thorough research is needed on the possible advantages and dangers of CBD, dosage, administration, and how it interacts with other cancer treatments. There are currently no FDA-approved CBD products for cancer. So, except for Epidiolex for epilepsy, the FDA has not examined the medications that are now available.
Nonetheless, some patients use cannabis to alleviate the negative effects of cancer therapy. Because CBD may interfere with other cancer medications, it is essential to see your doctor before beginning to take it.